|Articles|February 1, 2004

Prospective study confirms contrast sensitivity benefits of IOL

Eugene, OR-Implantation of the anterior surface modified prolate IOL (Tecnis, Pfizer Ophthalmics) results in improved functional vision for cataract surgery patients compared with a standard spherical IOL, said Mark D. Packer, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME